Form D · Other Health Care
NeuroGeneces, Inc.
Santa Fe, NM · CIK 0001716111
Offering snapshot reported May 1, 2026 · SEC filing
- Reported sold
- $425K Offering amount: $750K
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 14, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 1, 2026 | Initial | $425,000 | No comparison | 13 | SEC filing |
| Jan 28, 2019 | Amendment | $130,000 | No comparison | 4 | SEC filing |
| Apr 19, 2018 | Initial | $0 | No comparison | 1 | SEC filing |
| Sep 11, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-582588
Source: Form D, filed May 1, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Karen Crow | Director, Executive |
| Barry Jason Worchel | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1012 Marquez Place #207 A
Santa Fe, NM, 87505
Santa Fe, NM, 87505